Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians
- PMID: 31683290
- PMCID: PMC8152103
- DOI: 10.7326/M19-0642
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians
Erratum in
-
Correction: Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults.Ann Intern Med. 2020 Apr 7;172(7):512. doi: 10.7326/L20-0137. Ann Intern Med. 2020. PMID: 32252082 No abstract available.
-
Correction: Previously Undisclosed Potential Conflict of Interest by an Author of American College of Physicians Clinical Guidelines.Ann Intern Med. 2023 Apr;176(4):584. doi: 10.7326/L23-0043. Epub 2023 Feb 14. Ann Intern Med. 2023. PMID: 36780651 No abstract available.
Abstract
Description: The purpose of this guidance statement is to guide clinicians on colorectal cancer screening in average-risk adults.
Methods: This guidance statement is derived from a critical appraisal of guidelines on screening for colorectal cancer in average-risk adults and the evidence presented in these guidelines. National guidelines published in English between 1 June 2014 and 28 May 2018 in the National Guideline Clearinghouse or Guidelines International Network library were included. The authors also included 3 guidelines commonly used in clinical practice. Web sites were searched for guideline updates in December 2018. The AGREE II (Appraisal of Guidelines for Research and Evaluation II) instrument was used to evaluate the quality of guidelines.
Target audience and patient population: The target audience is all clinicians, and the target patient population is adults at average risk for colorectal cancer.
Guidance statement 1: Clinicians should screen for colorectal cancer in average-risk adults between the ages of 50 and 75 years.
Guidance statement 2: Clinicians should select the colorectal cancer screening test with the patient on the basis of a discussion of benefits, harms, costs, availability, frequency, and patient preferences. Suggested screening tests and intervals are fecal immunochemical testing or high-sensitivity guaiac-based fecal occult blood testing every 2 years, colonoscopy every 10 years, or flexible sigmoidoscopy every 10 years plus fecal immunochemical testing every 2 years.
Guidance statement 3: Clinicians should discontinue screening for colorectal cancer in average-risk adults older than 75 years or in adults with a life expectancy of 10 years or less.
Conflict of interest statement
Figures
Comment in
-
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults.Ann Intern Med. 2020 Apr 7;172(7):506-507. doi: 10.7326/L20-0112. Ann Intern Med. 2020. PMID: 32252078 No abstract available.
-
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults.Ann Intern Med. 2020 Apr 7;172(7):507-508. doi: 10.7326/L20-0113. Ann Intern Med. 2020. PMID: 32252079 No abstract available.
-
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults.Ann Intern Med. 2020 Apr 7;172(7):508. doi: 10.7326/L20-0114. Ann Intern Med. 2020. PMID: 32252080 No abstract available.
-
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults.Ann Intern Med. 2020 Apr 7;172(7):508-509. doi: 10.7326/L20-0115. Ann Intern Med. 2020. PMID: 32252081 No abstract available.
Similar articles
-
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians (Version 2).Ann Intern Med. 2023 Aug;176(8):1092-1100. doi: 10.7326/M23-0779. Epub 2023 Aug 1. Ann Intern Med. 2023. PMID: 37523709
-
Screening for colorectal cancer: a guidance statement from the American College of Physicians.Ann Intern Med. 2012 Mar 6;156(5):378-86. doi: 10.7326/0003-4819-156-5-201203060-00010. Ann Intern Med. 2012. PMID: 22393133
-
Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians.Ann Intern Med. 2019 Apr 16;170(8):547-560. doi: 10.7326/M18-2147. Epub 2019 Apr 9. Ann Intern Med. 2019. PMID: 30959525
-
Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations.World J Gastroenterol. 2018 Jan 7;24(1):124-138. doi: 10.3748/wjg.v24.i1.124. World J Gastroenterol. 2018. PMID: 29358889 Free PMC article. Review.
-
Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians.Ann Intern Med. 2018 Apr 17;168(8):569-576. doi: 10.7326/M17-0939. Epub 2018 Mar 6. Ann Intern Med. 2018. PMID: 29507945 Review.
Cited by
-
Examining the Sustainability of Core Capacity and Evidence-Based Interventions for FIT-Based CRC Screening: California Colorectal Cancer Control Program.Cancer Control. 2024 Jan-Dec;31:10732748241255218. doi: 10.1177/10732748241255218. Cancer Control. 2024. PMID: 39058902 Free PMC article.
-
Outcomes of Colorectal Endoscopic Submucosal Dissection for Elderly Patients: A Multicenter Study by the Honam Association for the Study of Intestinal Disease (HASID).In Vivo. 2024 May-Jun;38(3):1405-1411. doi: 10.21873/invivo.13582. In Vivo. 2024. PMID: 38688593 Free PMC article.
-
Colorectal Cancer: Epidemiology, Risk Factors, and Prevention.Cancers (Basel). 2024 Apr 17;16(8):1530. doi: 10.3390/cancers16081530. Cancers (Basel). 2024. PMID: 38672612 Free PMC article. Review.
-
Effectiveness of Colonoscopy Screening vs Sigmoidoscopy Screening in Colorectal Cancer.JAMA Netw Open. 2024 Feb 5;7(2):e240007. doi: 10.1001/jamanetworkopen.2024.0007. JAMA Netw Open. 2024. PMID: 38421651 Free PMC article. Clinical Trial.
-
GC-MS-based metabolomics of volatile organic compounds in exhaled breath: applications in health and disease. A review.Front Mol Biosci. 2024 Jan 8;10:1295955. doi: 10.3389/fmolb.2023.1295955. eCollection 2023. Front Mol Biosci. 2024. PMID: 38298553 Free PMC article. Review.
References
-
- Qaseem A, Kansagara D, Lin JS, et al.; Clinical Guidelines Committee of the American College of Physicians. The development of clinical guidelines and guidance statements by the Clinical Guidelines Committee of the American College of Physicians: update of methods. Ann Intern Med. 2019;170:863–70. [PMID: 31181568] doi: 10.7326/M18-3290 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical